Three cases of fungemia in hiv-infected patients diagnosed through the use of mycobacterial blood culture bottles

Internal Medicine

Volumn 49, Issue 19, 2010, Pages 2179-2183

  Taniguchi, Tomohiro ^a   Ogawa, Yoshihiko ^a   Kasai, Daisuke ^a   Watanabe, Dai ^a   Yoshikawa, Kouhei ^a   Bando, Hiroki ^a   Yajima, Keishiro ^a   Tominari, Shinjiro ^a   Shiiki, Soichi ^b   Nishida, Yasuharu ^a   Uehira, Tomoko ^a   Shirasaka, Takuma ^a  

^a OSAKA NATIONAL HOSPITAL   (Japan)

^b Okinawa Prefectural Chubu Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; ATAZANAVIR PLUS RITONAVIR; COTRIMOXAZOLE; EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; FLUCONAZOLE; FLUCYTOSINE; FOSAMPRENAVIR; LOPINAVIR PLUS RITONAVIR; MEROPENEM; SULTAMICILLIN; VANCOMYCIN; VORICONAZOLE;

ADULT; ANALYTICAL EQUIPMENT; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; ASPIRATION PNEUMONIA; BLOOD CULTURE; CANDIDA ALBICANS; CANDIDEMIA; CASE REPORT; CD4 LYMPHOCYTE COUNT; CRYPTOCOCCAL MENINGITIS; CRYPTOCOCCUS NEOFORMANS; CULTURE MEDIUM; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FUNGEMIA; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LARGE CELL LYMPHOMA; MALE; MYCOBACTERIAL BLOOD CULTURE BOTTLE; PENICILLIUM MARNEFFEI; PNEUMOCYSTIS PNEUMONIA; SEPSIS; VIRUS LOAD;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CANDIDA ALBICANS; CANDIDIASIS; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; CULTURE MEDIA; FUNGEMIA; HUMANS; MALE; MIDDLE AGED; MYCOLOGY; PENICILLIUM;

EID: 77958097163     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.49.3811     Document Type: Article

References (10)

1. Morrell M, Fraser VJ, Kollef MH. Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother 49: 3640-3645, 2005.
2. Edmond MB, Wallace SE, McClish DK, Pfaller MA, Jones RN, Wenzel RP. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis 29: 239-244, 1999.
3. Jones JM. Laboratory diagnosis of invasive candidiasis. Clin Microbiol Rev 3: 32-45, 1990.
4. Odabasi Z, Mattiuzzi G, Estey E, et al. Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin Infect Dis 39: 199-205, 2004.
5. Meyer MH, Letscher-Bru V, Jaulhac B, Waller J, Candolfi E. Comparison of Mycosis IC/F and plus Aerobic/F media for diagnosis of fungemia by the bactec 9240 system. J Clin Microbiol 42: 773-777, 2004.
6. Chiarini A, Palmeri A, Amato T, Immordino R, Distefano S, Giammanco A. Detection of bacterial and yeast species with the Bactec 9120 automated system with routine use of aerobic, anaerobic, and fungal media. J Clin Microbiol 46: 4029-4033, 2008.
7. Horvath LL, George BJ, Murray CK, Harrison LS, Hospenthal DR. Direct comparison of the BACTEC 9240 and BacT/ALERT 3 D automated blood culture systems for candida growth detection. J Clin Microbiol 42: 115-118, 2004.
8. Sivasangeetha K, Harish BN, Sujatha S, Parija SC, Dutta TK. Cryptococcal meningoencephalitis diagnosed by blood culture. Indian J Med Microbiol 25: 282-284, 2007.
9. Wu TC, Chan JW, Ng CK, Tsang DN, Lee MP, Li PC. Clinical presentations and outcomes of Penicillium marneffei infections: a series from 1994 to 2004. Hong Kong Med J 14: 103-109, 2008.
10. Fricker-Hidalgo H, Lebeau B, Pelloux H, Grillot R. Use of the BACTEC 9240 System with Mycosis-IC/F blood culture bottles for detection of fungemia. J Clin Microbiol 42: 1855-1856, 2004.